JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Financials | 11.13% |
| 3 | Consumer Discretionary | 10.11% |
| 4 | Healthcare | 9.61% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$926M
| $2.95M | ﹤0.01% |
216,092
| – | – |
|
3302
Seres Therapeutics
MCRB
$45.6M
| $2.94M | ﹤0.01% |
7,150
-585
| -8% | -$269K |
|
|
MRNS
3303
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.94M | ﹤0.01% |
190,093
+27,834
| +17% | +$403K |
|
3304
CALL
Beyond Meat
BYND
$232M
| $2.94M | ﹤0.01% |
+753
| New | +$3.32M |
|
|
AEPPZ
3305
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $2.93M | ﹤0.01% |
60,000
+40,000
| +200% | +$1.93M |
|
|
CTLP
3306
PUT
DELISTED
Cantaloupe
CTLP
| $2.93M | ﹤0.01% |
+250,000
| New | +$2.64M |
|
|
ABTX
3307
DELISTED
Allegiance Bancshares
ABTX
| $2.93M | ﹤0.01% |
72,266
+11,455
| +19% | +$437K |
|
3308
Standard BioTools
LAB
$280M
| $2.92M | ﹤0.01% |
646,808
-565,903
| -47% | -$3.11M |
|
3309
Stock Yards Bancorp
SYBT
$2.64B
| $2.91M | ﹤0.01% |
57,019
-4,521
| -7% | -$217K |
|
3310
CALL
PTC Therapeutics
PTCT
$5.98B
| $2.91M | ﹤0.01% |
+61,400
| New | +$3.65M |
|
|
TPTX
3311
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.91M | ﹤0.01% |
30,723
-16,996
| -36% | -$2.02M |
|
3312
Tootsie Roll Industries
TR
$3.08B
| $2.88M | ﹤0.01% |
100,901
+40,117
| +66% | +$1.1M |
|
3313
Ezcorp Inc
EZPW
$1.81B
| $2.88M | ﹤0.01% |
579,898
-4,631
| -0.8% | -$23.3K |
|
|
FVT
3314
DELISTED
Fortress Value Acquisition Corp. III
FVT
| $2.88M | ﹤0.01% |
+291,600
| New | +$2.91M |
|
3315
Invesco S&P 500 Pure Growth ETF
RPG
$2.1B
| $2.88M | ﹤0.01% |
87,495
-19,120
| -18% | -$632K |
|
|
EGRX
3316
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.87M | ﹤0.01% |
68,722
-6,813
| -9% | -$316K |
|
3317
Scholastic
SCHL
$781M
| $2.87M | ﹤0.01% |
95,198
+32,106
| +51% | +$903K |
|
3318
Sixth Street Specialty
TSLX
$1.78B
| $2.86M | ﹤0.01% |
136,144
+7,189
| +6% | +$154K |
|
3319
Amneal Pharmaceuticals
AMRX
$6.32B
| $2.85M | ﹤0.01% |
424,102
-63,570
| -13% | -$352K |
|
|
ECOL
3320
DELISTED
US Ecology, Inc.
ECOL
| $2.85M | ﹤0.01% |
68,546
+25,669
| +60% | +$999K |
|
|
PGTI
3321
DELISTED
PGT, Inc.
PGTI
| $2.85M | ﹤0.01% |
113,014
-28,554
| -20% | -$670K |
|
3322
iShares Europe ETF
IEV
$1.7B
| $2.84M | ﹤0.01% |
56,602
-5,610
| -9% | -$277K |
|
|
DAO
3323
Youdao
DAO
$2.17B
| $2.84M | ﹤0.01% |
119,225
-126,909
| -52% | -$4.03M |
|
|
POLY
3324
DELISTED
Plantronics, Inc.
POLY
| $2.84M | ﹤0.01% |
72,876
+8,005
| +12% | +$301K |
|
3325
Scholar Rock
SRRK
$6.4B
| $2.83M | ﹤0.01% |
55,921
-4,133
| -7% | -$229K |
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $27.4B of net new capital in Q1 2021, opening 866 new positions and adding to 2,870 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 462 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.